HiDO Health

Industry
Healthcare Technology
Founded Year
2018
Headquarters
El Dorado Hills, California
Employee Count
15

Key People

  • Charles Gellman - Co-Founder and CEO
  • Brandon Woolsey - Co-Founder & CTO
  • Christopher Knox - RVP Strategic Accounts
  • Steve Sandquist - Business Development Consultant
  • Thatiane Gellman - Business Development Manager

Assessment

Team
Aspect: First-time 10+ yrs
Summary: The leadership team comprises first-time entrepreneurs with over a decade of experience in their respective fields.

While the leadership team brings significant experience, their lack of prior entrepreneurial success in the MedTech sector may pose challenges in navigating the complexities of the industry.

Clinical Need
Aspect: Very Strong
Summary: HiDO Health addresses a critical need in reducing medication errors and improving patient adherence at home.

By focusing on medication adherence and error reduction, HiDO Health's technology has the potential to significantly improve patient health outcomes and reduce healthcare expenditures.

Competition
Aspect: First mover
Summary: HiDO Health appears to be a pioneer in AI-assisted home care robotics for medication adherence.

As a first mover, HiDO Health has the advantage of setting industry standards but may also face challenges related to market education and acceptance.

Technical Challenge
Aspect: Complex
Summary: Developing AI-assisted robotics for home care involves significant technical complexities.

The integration of AI and robotics in home care settings presents complex technical challenges, including ensuring reliability, user-friendliness, and compliance with healthcare standards.

Patent
Aspect: Applied
Summary: HiDO Health has applied for patents to protect its technology.

Securing patents is crucial for protecting intellectual property and maintaining a competitive advantage in the market.

Financing
Aspect: SBIR/SEED
Summary: The company has secured seed funding and SBIR grants.

While seed funding and grants provide a solid foundation, scaling operations will likely require further investment.

Regulatory
Aspect: Running FIH
Summary: HiDO Health is conducting first-in-human trials.

Successfully conducting first-in-human trials is essential for demonstrating safety and efficacy, paving the way for regulatory approval.

Opportunity Rollup

Odds of Success
3.5
Peak Market Share
5
Segment CAGR
10.7%
Market Segment
Home Healthcare Devices
Market Sub Segment
AI-Assisted Medication Adherence
Year Post Launch Market Penetration (%)
1 0.25
2 0.75
3 1.75
4 3.50
5 5.00

Key Takeaway

HiDO Health's AI-assisted robotics address a critical need in home healthcare, offering significant potential despite technical and market challenges.